ARCHIVES

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

This article is from The Cancer Letter archive.

Vol. 12 No. 07 | February 14, 1986

Download PDF Visit The Full Archive

Related Articles

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

March 28, 2008

Capitol Hill: Bills Seeks Coverage for Treatment Of cancers Found in CDC Screening

April 2, 1999

Breslow Reported Choice As HEW Asst. secretary

January 28, 1977

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

Avoiding Mediastinal Radiation Can Improve Patient Outcomes

April 26, 2013

House Approves Waxman Bill Unanimously; Hatch Introduces His Measure

June 21, 1985